4/14
08:35 am
clrb
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
Low
Report
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
3/10
08:40 am
clrb
Cellectar Biosciences (CLRB) was upgraded by Maxim Group from "hold" to "buy". They now have a $10.00 price target on the stock.
Medium
Report
Cellectar Biosciences (CLRB) was upgraded by Maxim Group from "hold" to "buy". They now have a $10.00 price target on the stock.
3/4
10:17 am
clrb
Cellectar (CLRB) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Cellectar (CLRB) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/4
07:51 am
clrb
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates [Yahoo! Finance]
Medium
Report
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates [Yahoo! Finance]
3/4
07:15 am
clrb
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
Medium
Report
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
2/25
08:05 am
clrb
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
Low
Report
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
2/17
08:05 am
clrb
Cellectar Biosciences Expands Global Intellectual Property Estate
High
Report
Cellectar Biosciences Expands Global Intellectual Property Estate